Position in REGN
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$685,331
+$276,240 QoQ
Shares Held
887
+67.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STEPHENS INC /AR/ holds $6,968,085 across 12 Biotechnology names. REGN ranks #3 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
26,761 | $2,009,483 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,951 | $1,317,739 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
887 | $685,331 | |
| 4 | TECH |
BIO-TECHNE Corp
|
12,422 | $649,173 | |
| 5 | EXEL |
Exelixis, Inc.
|
13,634 | $584,762 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,425 | $471,489 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
1,625 | $324,431 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
4,557 | $294,518 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $685,331 | 887 | Shares | Defined | 2026-04-28 | |
| 2025-12-31 | $409,091 | 530 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $304,188 | 541 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $392,700 | 748 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $566,367 | 893 | Shares | Defined | 2025-05-01 | |
| 2024-12-31 | $675,288 | 948 | Shares | Defined | 2025-01-28 | |
| 2024-09-30 | $1,002,882 | 954 | Shares | Defined | 2024-10-28 | |
| 2024-06-30 | $1,003,733 | 955 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $878,753 | 913 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $633,247 | 721 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $524,225 | 637 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $461,302 | 642 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $531,620 | 647 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $518,751 | 719 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $495,297 | 719 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $430,933 | 729 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $511,243 | 732 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $462,272 | 732 | Shares | Defined | 2022-03-07 | |
| 2021-09-30 | $446,017 | 737 | Shares | Defined | 2021-10-27 | |
| 2021-06-30 | $415,553 | 744 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $399,330 | 844 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $6,881,901 | 14,245 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $7,426,601 | 13,267 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $8,118,675 | 13,018 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $6,427,361 | 13,163 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||